These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3186649)

  • 21. Effects of resistive load on the phase difference between chest and mouth flow in patients with chronic obstructive pulmonary disease.
    Mishima M; Higashiya K; Kawakami K; Sugiura N; Sakai N; Hirai T; Oku Y; Chin K; Ohi M; Kuno K
    Front Med Biol Eng; 1997; 8(1):1-18. PubMed ID: 9083797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of atenolol on airway resistance in hypertensive patients with chronic obstructive lung disease].
    Molho M; Lidgy M; Ezra D; Rosenthal T
    Harefuah; 1981 Mar; 100(5):220-2. PubMed ID: 7286815
    [No Abstract]   [Full Text] [Related]  

  • 23. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I
    Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep.
    Prielipp RC; Rosenthal MH; Pearl RG
    Anesth Analg; 1988 Aug; 67(8):722-9. PubMed ID: 3293483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lung function in chronic persistent pulmonary embolism].
    Fischer BM; Kreiselmeyer M; Schlegel J; Schadmand S; Iversen S; Rupprecht HJ; Lorenz J; Ferlinz R
    Pneumologie; 1995 Apr; 49(4):273-6. PubMed ID: 7792286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Obstructive pulmonary hypertension: effect of aminophylline, hyperventilation and O 2 respiration].
    Renggli I; Daum S
    Schweiz Med Wochenschr; 1971 Mar; 101(10):352-7. PubMed ID: 5558550
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease.
    Franz IW; Van Der Meyden J; Schaupp S; Tönnesmann U
    Z Kardiol; 2002 Oct; 91(10):833-9. PubMed ID: 12395224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 30. [Favorable response of pulmonary hypertension in patients with chronic obstructive airway disease treated with diltiazem].
    Gassner A
    Schweiz Med Wochenschr; 1984 Mar; 114(10):332-7. PubMed ID: 6710104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Symptomatic hypertension in chronic obstructive diseases of the lungs (based on data from the Armenian SSR)].
    Eramian SG; Airapetian TsS
    Klin Med (Mosk); 1972 Dec; 50(12):116-20. PubMed ID: 4660494
    [No Abstract]   [Full Text] [Related]  

  • 33. Very high-dose prostaglandin E1 requirement for heart transplantation.
    Dorman BH; Harvey SC; Conroy JM; Crumbley AJ; Handy JR; Uber WE; Brahen NH
    J Heart Lung Transplant; 1992; 11(4 Pt 1):724-6. PubMed ID: 1498138
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term prazosin therapy for COPD pulmonary hypertension.
    Lewczuk J; Sobkowicz-Woźniak B; Piszko P; Spikowski J; Wrabec K
    Chest; 1992 Aug; 102(2):635-6. PubMed ID: 1643964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E1 in primary pulmonary hypertension.
    Swan PK; Tibballs J; Duncan AW
    Crit Care Med; 1986 Jan; 14(1):72-3. PubMed ID: 3940758
    [No Abstract]   [Full Text] [Related]  

  • 36. Intrapulmonary shunt fraction and prostaglandin E1.
    Heerdt PM
    Anesth Analg; 1998 Jul; 87(1):233. PubMed ID: 9661585
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary edema after PGE1 infusion.
    White JL; Fleming NW; Burke TA; Katz NM; Moront MG; Kim YD
    J Cardiothorac Anesth; 1990 Dec; 4(6):744-7. PubMed ID: 2131906
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
    Weir DC; Burge PS
    Thorax; 1990 Nov; 45(11):907-8. PubMed ID: 2256027
    [No Abstract]   [Full Text] [Related]  

  • 39. [Role of heparin in the treatment of decompensated chronic obstructive bronchopneumopathies].
    Wipf R; Stinghe R
    Rev Med Suisse Romande; 1977 Nov; 97(11):525-30. PubMed ID: 601376
    [No Abstract]   [Full Text] [Related]  

  • 40. [Alprostadil the pneumoconiosis rheology and respiratory function of patients with pulmonary heart disease clinical research].
    Lui CY; Gong XW; Chen Q
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Sep; 30(9):694-6. PubMed ID: 23257099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.